Annovis Bio’s common stock is listed on the NYSE under the symbol “ANVS”.
Annovis Bio is headquartered at 101 Lindenwood Drive, Suite 225, Malvern, PA 19355.
Annovis Bio is incorporated under the laws of the State of Delaware.
Annovis Bio’s fiscal year end is December 31.
Shares can be purchased through a stockbroker of your choice.
Annovis Bio’s auditor is Ernst and Young LLP.
Please contact our transfer agent, EQ Shareowner Services, through their website or by phone at 800-468-9716. The company can look up your records and make any necessary adjustments. There might be fee involved for replacing lost certificates.
Annovis Bio’s legal counsel is Loeb & Loeb, LLP.
You can view our recent press releases by visiting the News section of our website here.
More information can be found on the Annovis Bio website and the SEC website.
Annovis Bio’s initial public offering of its common stock occurred on January 29, 2020.
Annovis Bio was founded in May 2008.
You can view our management team and Board of Directors by visiting our website here.
For Annovis Bio’s common shares listed on the NYSE, the CUSIP number is 03615A108.
Currently, Annovis Bio does not pay dividends.
EQ Shareowner Services PO Box 64874 St Paul MN 55164-0874. Phone# 800-468-9716
You must send both your old and new addresses to our transfer agent, Equiniti Trust Company, LLC, by U.S. mail. Each stockholder in question must sign the request for an address change.
You can view information on our platform and programs by visiting the Technologies section of our website here.
Quarterly & Annual Reports and other investor materials are available under SEC Filings of the Investors section of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
Annovis Bio Investor Relations
ir@annovisbio.com